Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue from awards and licenses $ 881,705 $ 3,937,230
Operating expenses:    
Research and development 36,445,285 98,267,213
General and administrative 20,425,444 28,480,250
Total operating expenses 56,870,729 126,747,463
Operating loss (55,989,024) (122,810,233)
Other income (expense), net:    
Other income (expense), net 11,899,992 13,270,211
Interest income (expense), net (1,830,486) (1,028,359)
Change in fair value of derivative liability 663,290 (251,000)
Foreign currency exchange gain (loss) (384,198) (449,999)
Other income (expense), net 10,348,598 11,540,853
Net loss $ (45,640,426) $ (111,269,380)
Net loss per share, basic and diluted $ (0.37) $ (1.42)
Weighted average number of common shares outstanding, basic and diluted 122,990,011 78,133,289
Comprehensive loss:    
Net loss $ (45,640,426) $ (111,269,380)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable debt securities (62,445)
Total other comprehensive income (loss) (62,445)
Total comprehensive loss $ (45,702,871) $ (111,269,380)